Adempas FDA Approval History
FDA Approved: Yes (First approved October 8, 2013)
Brand name: Adempas
Generic name: riociguat
Dosage form: Tablets
Company: Bayer HealthCare Pharmaceuticals Inc.
Treatment for: Pulmonary Hypertension
Adempas (riociguat) is an oral soluble guanylate cyclase (sGC) stimulator for the treatment of pulmonary hypertension.
Development Timeline for Adempas
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.